Synthesis and Hypoglycemic Effect of Chrysin Derivatives
Overview
Affiliations
A series of 18 chrysin derivatives, prepared by alkylation and condensation, were fully characterized by NMR and other techniques and tested in vivo against the diabetes mellitus. Several modified compounds especially those with propyl, butyl, octyl and tolyl groups were found to have hypoglycemic effect on diabetec mice in spite of the fact that chrysin itself had inhibited insulin release by 40-60%. None of the test animals died at the maximum dose 500mg/kg and did not cause any significant change in general feature, water and food consumption, body weight and organ weight when we examined the acute oral toxicity of those compounds having significant hypoglycemic effect.
Jeong S, Kim H, Ha S, Park M, Bhosale P, Abusaliya A Int J Mol Sci. 2022; 23(18).
PMID: 36142874 PMC: 9505532. DOI: 10.3390/ijms231810965.
Zhang R, Zhang Y, Huang G, Xin X, Tang L, Li H RSC Adv. 2022; 11(61):38703-38711.
PMID: 35493254 PMC: 9044198. DOI: 10.1039/d1ra07753h.
Geng A, Xu S, Yao Y, Qian Z, Wang X, Sun J Cell Cycle. 2022; 21(4):379-391.
PMID: 34985375 PMC: 8855858. DOI: 10.1080/15384101.2021.2020434.
Rubio A, Gonzalez R, Busto N, Vaquero M, Iglesias A, Jalon F Pharmaceutics. 2021; 13(10).
PMID: 34683834 PMC: 8537477. DOI: 10.3390/pharmaceutics13101540.
Emerging cellular and molecular mechanisms underlying anticancer indications of chrysin.
Talebi M, Talebi M, Farkhondeh T, Simal-Gandara J, Kopustinskiene D, Bernatoniene J Cancer Cell Int. 2021; 21(1):214.
PMID: 33858433 PMC: 8050922. DOI: 10.1186/s12935-021-01906-y.